ABSTRACT
OBJECTIVES: Despite research showing higher use of amphetamine-type stimulants (ATS) in rural areas, limited research has examined the epidemiology of ATS-related presentations and admissions to remote regional centres. To determine the epidemiology of ATS-related (a) Emergency Department (ED) presentations and (b) inpatient admissions over a five-year period at the Hedland Health Campus (HHC) in remote Western Australia. METHODS: A retrospective review of medical records was conducted. Demographic data including gender, age and indigenous status were captured. RESULTS: Four hundred and eighty-two ATS-related hospital presentations were identified during the study period. The most common reason for ED presentation was mental and behavioural problems. Of those presenting, 66% were male and 69% identified as Aboriginal. ATS-related ED presentations increased seven-fold over the study period. Ninety-nine ATS-related inpatient admissions were identified during the study period. Psychotic disorder was the most common reason for admission. Males made up 75% of admissions and 53% identified as Aboriginal. CONCLUSIONS: This study showed a disproportionally high burden of ATS-related harm among Aboriginal people. The number of ATS-related ED presentations and inpatient admissions increased significantly over the study period.
Subject(s)
Amphetamine-Related Disorders/epidemiology , Amphetamines/adverse effects , Central Nervous System Stimulants/adverse effects , Emergency Service, Hospital/statistics & numerical data , Patient Admission/statistics & numerical data , Psychoses, Substance-Induced/epidemiology , Adolescent , Adult , Amphetamine-Related Disorders/ethnology , Amphetamine-Related Disorders/therapy , Female , Humans , Male , Middle Aged , Psychoses, Substance-Induced/ethnology , Psychoses, Substance-Induced/therapy , Retrospective Studies , Western Australia/epidemiology , Young AdultABSTRACT
GABA system genes have been implicated in neurotrophy and neurogenesis, which play pivotal roles in an individual's variation in vulnerability to amphetamine addiction or amphetamine-induced psychosis (AIP). We hypothesized that common genetic variants in the GABA system genes may be associated with amphetamine-induced psychotic disorder. In our study, thirty-six single nucleotide polymorphisms (SNPs) within the GABA system genes were genotyped in 400 amphetamine-induced psychotic disorder patients and 400 amphetamine use disorders patients (AUP) (not including those categorized as psychosis) in the Han Chinese population. In this study, 51.88% of the Han Chinese amphetamine-type substance use disorder patients met the criteria of amphetamine-induced psychotic disorder, and 79.5% amphetamine-induced psychotic disorder patients had auditory hallucinations, while 46.5% had delusions of reference. The allele frequency of rs1129647 showed nominal association with AIP in the Han Chinese population (P=0.03). Compared with AUP group patients, T allele frequency of AIP group patients was significantly increased. The adjustment for age and gender factors in the AIP and AUP patients was executed using unconditional logistic regression under five inheritance models. The genotype frequency of rs1129647 showed nominal association with AIP in the log-additive model (P=0.04). The genotype frequency of rs2290733 showed nominal association with AIP in the recessive model (P=0.04). Compared with female AIP patients, male patients were more likely to have the CC genotype of rs17545383 (P=0.04). Moreover, we determined that more male patients carried the T allele of rs2290733 in the AIP group (P=0.004). Unfortunately, the significant differences did not survive Benjamini-Hochberg false discovery rate correction (adjusted P>0.05). No association between the SNPs of the GABA system genes and amphetamine-induced psychotic disorder risk was identified. No haplotype of the GABA system genes affected amphetamine-induced psychotic disorder risk. This report describes the first association study between the GABA system genes and amphetamine-induced psychotic disorder in the Han Chinese population. Our data may provide a reference for future research.
Subject(s)
Amphetamine/adverse effects , Psychoses, Substance-Induced/genetics , gamma-Aminobutyric Acid/genetics , Adult , Asian People , Case-Control Studies , Female , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease , Humans , Male , Polymorphism, Single Nucleotide , Psychoses, Substance-Induced/ethnology , Receptors, GABA-A/genetics , RiskABSTRACT
PURPOSE: Khat use has been suggested to be associated with psychosis, but its prevalence and associations among mental health service users have not been described in either traditional use countries or countries with immigrant populations from traditional use countries. We aimed to investigate the clinical and demographic associations of khat use in a sample of Somali users of mental health service users in South London. METHODS: We used an electronic case register of 150,000 mental health patients to investigate the associations of khat use among all 240 Somali patients in the database. We used logistic regression to generate adjusted estimates for a range of exposure variables and used multiple imputation as a principled approach to missing data. RESULTS: Khat use or non-use was recorded for 172 patients (72% of the total), of whom 80 (47%) were current users. Khat use was very strongly associated with ICD-10 primary diagnosis of schizophrenia, psychosis or drug and alcohol disorder (compared to ICD-10 F43 stress-related disorders and other non-psychotic disorders), male gender, harmful or dependent use of alcohol, and detention under the Mental Health Act. CONCLUSIONS: Recording and monitoring of khat use need to be more consistent in clinical settings, and further studies are required to investigate the much higher rates of use among those with psychotic disorders compared to non-psychotic disorders.
Subject(s)
Catha/adverse effects , Mental Health Services/statistics & numerical data , Psychoses, Substance-Induced/ethnology , Psychotropic Drugs/adverse effects , Adolescent , Adult , Aged , Cross-Sectional Studies , Female , Humans , International Classification of Diseases , Logistic Models , London/epidemiology , Male , Middle Aged , Plant Leaves , Prevalence , Psychoses, Substance-Induced/psychology , Risk Factors , Socioeconomic Factors , Somalia/ethnology , Young AdultABSTRACT
This paper reflects the intersection of three cultures: the rave (all night dance party and use of the drug, Ecstasy) culture; the ward culture of an inpatient psychiatric program for First Episode Psychosis; the spirit healing culture of the Philippines. All three intersected in Toronto, Canada in the mid 1990s, as illustrated by the clinical case of a 19-year-old university student who was hospitalized with symptoms of drug-induced psychosis. Her initial treatment was not successful and presented dilemmas for the treating staff. Transfer to a second psychiatric facility that permitted attendance at a traditional Filipino healing ceremony resulted in a cure, with no recurrence 10 years later. According to James Dow's 1986 formulation, the components of the key spiritual healing session paralleled the very elements the young woman had sought by participating in raves, an activity that was problematic because it led to family displeasure. Whereas attendance at a rave triggered illness, the healing session, sanctioned by her family and taking place in their midst, resulted in healing.
Subject(s)
Amphetamine-Related Disorders/ethnology , Cross-Cultural Comparison , Dancing/psychology , Emigrants and Immigrants/psychology , N-Methyl-3,4-methylenedioxyamphetamine , Psychoses, Substance-Induced/ethnology , Refugees/psychology , Spiritual Therapies , Amphetamine-Related Disorders/psychology , Amphetamine-Related Disorders/rehabilitation , Female , Hospitalization , Humans , Ontario , Patient Transfer , Philippines/ethnology , Psychoses, Substance-Induced/psychology , Psychoses, Substance-Induced/rehabilitation , Religion and Psychology , Social Values , Treatment Failure , Young AdultABSTRACT
OBJECTIVE: To determine if substance use (particularly cannabis) is more frequent among first episode psychosis patients and associated with a more problematic clinical presentation. METHOD: All first episode psychosis (FEP) patients presenting to secondary services were recruited from London and Nottingham, over 2 years, in the Aetiology and Ethnicity of Schizophrenia and Other Psychoses study broad framework. Clinical and sociodemographic variables were assessed using a set of standardized instruments. A schedule was created to retrospectively collate substance use data from patients, relatives and clinicians. RESULTS: Five hundred and eleven FEP were identified. They used three to five times more substances than general population. Substance use was associated with poorer social adjustment and a more acute mode of onset. Cannabis use did not affect social adjustment, but was associated with a more acute mode of onset. CONCLUSION: Cannabis has a different impact on FEP than other substances. Large epidemiological studies are needed to disentangle cannabis effect.
Subject(s)
Illicit Drugs , Psychoses, Substance-Induced/epidemiology , Psychoses, Substance-Induced/rehabilitation , Psychotic Disorders/epidemiology , Psychotic Disorders/rehabilitation , Substance-Related Disorders/epidemiology , Substance-Related Disorders/rehabilitation , Acute Disease , Adolescent , Adult , Age of Onset , Comorbidity , Cross-Cultural Comparison , Cross-Sectional Studies , England , Female , Humans , Illicit Drugs/adverse effects , Male , Marijuana Abuse/epidemiology , Marijuana Abuse/rehabilitation , Middle Aged , Psychoses, Substance-Induced/ethnology , Psychotic Disorders/ethnology , Retrospective Studies , Social Adjustment , Substance-Related Disorders/ethnology , Young AdultABSTRACT
Substance use disorders are familial, and genetic factors explain a substantial degree of their familial aggregation. Methamphetamine (MAP) abusers are commonly noted as having psychosis, depression and suicidal behavior. The goals of the present study were (i) to investigate relations of clinical correlates, such as gender, drug use behavior, psychiatric comorbidity and psychiatry family history, with suicidal behavior among Chinese MAP abusers; and (ii) to investigate whether there is an association between a polymorphism in the promotor region of the serotonin transporter gene (5-HTTLPR) and suicidal behavior among Chinese MAP abusers. A total of 439 MAP abusers from a hospital and detention center in Taipei were interviewed with the Diagnostic Interview for Genetic Study and the Family Interview for Genetic Study. The 5-HTTLPR polymorphism was compared between 94 MAP abusers with suicide attempts and 294 MAP abusers without suicide attempts, for whom DNA data were available. The results of the present study indicate that among MAP abusers in Taiwan, suicide attempts were significantly related to female gender, history of MAP-induced psychotic disorder, history of MAP-induced depressive disorder, and family history of psychotic disorders. Among suicide attempters, the attempters with moderate to severe lethality used higher MAP doses than those with minimal to mild lethality. In the present sample the triallelic 5-HTTLPR polymorphism (S, L(G), L(A)) was not associated with MAP-induced depressive disorder, MAP-induced psychotic disorder or suicidal behavior, but studies with larger sample sizes are warranted before excluding the role of the 5-HTTLPR polymorphisms in suicidal behavior among MAP abusers.
Subject(s)
Amphetamine-Related Disorders/genetics , Asian People/genetics , Genetic Predisposition to Disease/genetics , Methamphetamine , Polymorphism, Genetic/genetics , Promoter Regions, Genetic/genetics , Serotonin Plasma Membrane Transport Proteins/genetics , Suicide, Attempted/psychology , Adult , Alleles , Amphetamine-Related Disorders/ethnology , Amphetamine-Related Disorders/psychology , Asian People/psychology , Comorbidity , Depressive Disorder/chemically induced , Depressive Disorder/ethnology , Depressive Disorder/genetics , Depressive Disorder/psychology , Female , Genetic Predisposition to Disease/ethnology , Genotype , Humans , Male , Psychoses, Substance-Induced/ethnology , Psychoses, Substance-Induced/genetics , Psychoses, Substance-Induced/psychology , Risk Factors , Statistics as Topic , Suicide, Attempted/ethnology , TaiwanABSTRACT
Isotretinoin (Accutane) is a drug closely related to the chemical structure of Vitamin A. The pharmacology and toxicology of these two retinoids is similar enough to warrant comparison. Accutane is a powerful drug which its manufacturer, Roche, indicates is limited for severe recalcitrant nodular acne. This potency is also reflected in Accutane's well-known ability to produce severe birth defects if taken during pregnancy. Less well-known is the risk of this lipid soluble chemical to affect the Central Nervous System. Reports of intracranial hypertension, depression, and suicidal indeation with Accutane use have prompted an examination of this serious and life threatening potential. Though Roche has added a warning to its product label for signs of depression and suicidal ideation, this product is being overprescribed for all forms of acne, including mild cases and moderate acne that have not been treated with alternative medications, which have a lesser risk of depression and suicide. There is no contesting that this drug is effective at clearing up the most severe forms of acne, but the public must be informed of its proper, limited indication for use; depression and suicide can follow in patients with no prior history of psychiatric symptoms or suicide attempts.